BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18631251)

  • 1. Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.
    Mohr L; Banerjee K; Kleinschmidt M; Bartolomé Rodríguez MM; Wands JR
    Hepatol Res; 2008 Dec; 38(12):1233-40. PubMed ID: 18631251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice.
    Mohr L; Tanaka S; Wands JR
    Gastroenterology; 1998 Dec; 115(6):1558-65. PubMed ID: 9834285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.
    Longato L; de la Monte S; Kuzushita N; Horimoto M; Rogers AB; Slagle BL; Wands JR
    Hepatology; 2009 Jun; 49(6):1935-43. PubMed ID: 19475691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis.
    Tanaka S; Wands JR
    Cancer Res; 1996 Aug; 56(15):3391-4. PubMed ID: 8758899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of human insulin receptor substrate 1 induces cellular transformation with activation of mitogen-activated protein kinases.
    Ito T; Sasaki Y; Wands JR
    Mol Cell Biol; 1996 Mar; 16(3):943-51. PubMed ID: 8622697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
    Welsh N; Makeeva N; Welsh M
    Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive over-expression of the insulin receptor substrate-1 causes functional up-regulation of Fas receptor.
    Wiedmann M; Tamaki S; Silberman R; de la Monte SM; Cousens L; Wands JR
    J Hepatol; 2003 Jun; 38(6):803-10. PubMed ID: 12763374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptor substrate-4 signaling in quiescent rat hepatocytes and in regenerating rat liver.
    Escribano O; Fernández-Moreno MD; Zueco JA; Menor C; Fueyo J; Ropero RM; Diaz-Laviada I; Román ID; Guijarro LG
    Hepatology; 2003 Jun; 37(6):1461-9. PubMed ID: 12774026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.
    Gingras S; Côté S; Simard J
    Mol Endocrinol; 2000 Feb; 14(2):229-40. PubMed ID: 10674396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis.
    Aleem E; Nehrbass D; Klimek F; Mayer D; Bannasch P
    Toxicol Pathol; 2011 Apr; 39(3):524-43. PubMed ID: 21411721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
    Annerén C; Welsh M
    Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
    Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
    J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted hepatic overexpression of human IRS-1: postnatal effects in the developing mouse.
    Giannone PJ; Abu Dayyeh BK; Bienieki TC; Wands JR; Gruppuso PA
    Biochim Biophys Acta; 2004 May; 1672(2):112-9. PubMed ID: 15110093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor stimulates proliferation of pancreatic beta-cells particularly in the presence of subphysiological glucose concentrations.
    Gahr S; Merger M; Bollheimer LC; Hammerschmied CG; Schölmerich J; Hügl SR
    J Mol Endocrinol; 2002 Apr; 28(2):99-110. PubMed ID: 11932207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
    Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
    Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.
    Jackson JG; White MF; Yee D
    J Biol Chem; 1998 Apr; 273(16):9994-10003. PubMed ID: 9545345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin signaling through insulin receptor substrate 1 and 2 in normal liver development.
    Khamzina L; Gruppuso PA; Wands JR
    Gastroenterology; 2003 Aug; 125(2):572-85. PubMed ID: 12891559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.